Cerebral Scanning Technology Detects Brain Pathologies
By HospiMedica International staff writers Posted on 15 Jan 2018 |
Image: A bioimpedance spectroscopy device detects blood flow in the brain (Photo courtesy of Cerebrotech).
A portable, non-invasive device detects asymmetry of intracranial fluid volumes in patients undergoing neurological assessment.
The Cerebrotech (Pleasanton, CA, USA) Visor is a novel bioimpedance spectroscopy device that detects changes and distribution of cerebral fluids using volumetric impedance phase-shift spectroscopy (VIPS). The device consists of a headband with multiple integrated antennas that broadcast and receive each other’s signals; the frequency response of the phase angle between a transmitter and receiver antenna represents changes in the electrical properties of tissue as a direct result of small changes in intracranial fluids.
A computer algorithm analyzes the changes in tissue electrical properties, providing a visual readout on a monitor of the detected changes. The ratio of bioimpedance measurements between the brain's right and left hemispheres, and especially changes in that ratio, can help detect any fluid asymmetry during neurologic assessment. Proprietary machine learning algorithms are then used to differentiate between the bioimpedance profiles of various brain pathologies, such as stroke, trauma, swelling, and others. The system has been approved by the U.S. Food and Drug Administration (FDA).
“We understand the challenges facing medical professionals who need to quickly assess patients with neurologic symptoms. The Cerebrotech Visor is designed to be portable, fast, and accurate,” said Mitch Levinson, CEO of Cerebrotech Medical Systems. “Utilizing the vast amount of data captured by our proprietary Cerebrotech Visor, our mission is to develop unique algorithms that can help physicians to better detect and diagnose a wide range of neurological conditions, improving outcomes for patients while reducing overall healthcare costs.”
“A simple, easy-to-use device that can provide accurate information about cerebral fluids in 30 seconds is an important development,” said neurologist Professor Andrei Alexandrov, MD, of the University of Tennessee Center for Health Science (Memphis, USA). “During neurologic assessment, presence and magnitude of fluid asymmetry is a critical piece of information that will help us understand and evaluate our patients. I see tremendous potential for this technology for a large cross-section of patients with neurologic symptoms and various conditions."
Related Links:
Cerebrotech
The Cerebrotech (Pleasanton, CA, USA) Visor is a novel bioimpedance spectroscopy device that detects changes and distribution of cerebral fluids using volumetric impedance phase-shift spectroscopy (VIPS). The device consists of a headband with multiple integrated antennas that broadcast and receive each other’s signals; the frequency response of the phase angle between a transmitter and receiver antenna represents changes in the electrical properties of tissue as a direct result of small changes in intracranial fluids.
A computer algorithm analyzes the changes in tissue electrical properties, providing a visual readout on a monitor of the detected changes. The ratio of bioimpedance measurements between the brain's right and left hemispheres, and especially changes in that ratio, can help detect any fluid asymmetry during neurologic assessment. Proprietary machine learning algorithms are then used to differentiate between the bioimpedance profiles of various brain pathologies, such as stroke, trauma, swelling, and others. The system has been approved by the U.S. Food and Drug Administration (FDA).
“We understand the challenges facing medical professionals who need to quickly assess patients with neurologic symptoms. The Cerebrotech Visor is designed to be portable, fast, and accurate,” said Mitch Levinson, CEO of Cerebrotech Medical Systems. “Utilizing the vast amount of data captured by our proprietary Cerebrotech Visor, our mission is to develop unique algorithms that can help physicians to better detect and diagnose a wide range of neurological conditions, improving outcomes for patients while reducing overall healthcare costs.”
“A simple, easy-to-use device that can provide accurate information about cerebral fluids in 30 seconds is an important development,” said neurologist Professor Andrei Alexandrov, MD, of the University of Tennessee Center for Health Science (Memphis, USA). “During neurologic assessment, presence and magnitude of fluid asymmetry is a critical piece of information that will help us understand and evaluate our patients. I see tremendous potential for this technology for a large cross-section of patients with neurologic symptoms and various conditions."
Related Links:
Cerebrotech
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergency Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure